0001354457-23-000329.txt : 20230502
0001354457-23-000329.hdr.sgml : 20230502
20230502133545
ACCESSION NUMBER: 0001354457-23-000329
CONFORMED SUBMISSION TYPE: 25-NSE
CONFIRMING COPY:
PUBLIC DOCUMENT COUNT: 2
FILED AS OF DATE: 20230502
DATE AS OF CHANGE: 20230502
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: PLx Pharma Inc.
CENTRAL INDEX KEY: 0001497504
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 271707962
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36351
BUSINESS ADDRESS:
STREET 1: 9 FISHERS LANE
STREET 2: SUITE E
CITY: SPARTA
STATE: NJ
ZIP: 07871
BUSINESS PHONE: (713) 842-1249
MAIL ADDRESS:
STREET 1: 9 FISHERS LANE
STREET 2: SUITE E
CITY: SPARTA
STATE: NJ
ZIP: 07871
FORMER COMPANY:
FORMER CONFORMED NAME: Dipexium Pharmaceuticals, Inc.
DATE OF NAME CHANGE: 20140313
FORMER COMPANY:
FORMER CONFORMED NAME: Dipexium Pharmaceuticals, LLC
DATE OF NAME CHANGE: 20100726
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: Nasdaq Stock Market LLC
CENTRAL INDEX KEY: 0001354457
IRS NUMBER: 521165937
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
BUSINESS ADDRESS:
STREET 1: One Liberty Plaza
CITY: New York
STATE: NY
ZIP: 10006
BUSINESS PHONE: 301-978-4144
MAIL ADDRESS:
STREET 1: Office of General Counsel
STREET 2: 805 King Farm Blvd.
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
FORMER COMPANY:
FORMER CONFORMED NAME: The Nasdaq Stock Market LLC
DATE OF NAME CHANGE: 20060224
25-NSE
1
primary_doc.xml
X0203
0001354457
Nasdaq Stock Market LLC
0001497504
PLx Pharma Inc.
001-36351
74 Broad Street
New York
NY
NEW YORK
10004
212-422-5717
Common stock
17 CFR 240.12d2-2(b)
Aravind Menon
Hearings Advisor
2023-05-02
EX-99.25
2
plxpdelistreason.txt
Delisting Determination, The Nasdaq Stock Market, LLC, May 2, 2023,
PLx Pharma Inc.
The Nasdaq Stock Market LLC (the Exchange) has determined to remove
from listing the common stock of PLx Pharma Inc., effective at the
opening of the trading session on May 12, 2023.
Based on review of information provided by the Company, Nasdaq
Staff determined that the Company no longer qualified for listing
on the Exchange pursuant to Listing Rules 5101, 5110(b), and
IM-5101-1. The Company was notified of the Staff determination
on April 4, 2023. The Company did not appeal the Staff determination
to the Hearings Panel. The Company securities were suspended on
April 13, 2023. The Staff determination to delist the Company
securities became final on April 13, 2023.